DO WE REALLY NEED PROGNOSTIC FACTORS FOR BREAST-CANCER

被引:75
作者
CLARK, GM
机构
[1] Division of Medical Oncology, University of Texas Health Science Center at San Antonio, San Antonio, 78284-7884, TX
关键词
CUTPOINT ANALYSIS; DRUG RESISTANCE; MARKERS; MULTIVARIATE MODELS; PROGNOSTIC FACTORS; PROGNOSTIC INDEXES; VALIDATION;
D O I
10.1007/BF00666054
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The role of prognostic factors in optimizing treatment for breast cancer patients has clearly changed with the trend toward general use of adjuvant therapy. Nevertheless, there are at least three situations in which prognostic factors could be helpful. The first is to identify patients whose prognosis is so good that adjuvant therapy after local surgery would not be cost-beneficial, The second is to identify patients whose prognosis is so poor that a more aggressive adjuvant approach would be warranted. The third is to identify patients likely to be responsive or resistant to particular forms of therapy. Here we will discuss all of these situations, together with the appropriate cutpoint analyses and validation of individual prognostic factors and their combination into prognostic indexes which may make the discrimination of patient subsets more reliable.
引用
收藏
页码:117 / 126
页数:10
相关论文
共 23 条
[1]   HER-2/NEU IN NODE-NEGATIVE BREAST-CANCER - PROGNOSTIC-SIGNIFICANCE OF OVEREXPRESSION INFLUENCED BY THE PRESENCE OF INSITU CARCINOMA [J].
ALLRED, DC ;
CLARK, GM ;
TANDON, AK ;
MOLINA, R ;
TORMEY, DC ;
OSBORNE, CK ;
GILCHRIST, KW ;
MANSOUR, EG ;
ABELOFF, M ;
EUDEY, L ;
MCGUIRE, WL .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (04) :599-605
[2]  
CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO
[3]  
2-H
[4]  
CIOCCA DR, 1992, CANCER RES, V52, P3648
[5]   HEAT-SHOCK PROTEIN-HSP70 IN PATIENTS WITH AXILLARY LYMPH NODE-NEGATIVE BREAST-CANCER - PROGNOSTIC IMPLICATIONS [J].
CIOCCA, DR ;
CLARK, GM ;
TANDON, AK ;
FUQUA, SAW ;
WELCH, WJ ;
MCGUIRE, WL .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (07) :570-574
[6]  
CLARK GM, 1993, CANCER-AM CANCER SOC, V71, P2157, DOI 10.1002/1097-0142(19930315)71:6+<2157::AID-CNCR2820711606>3.0.CO
[7]  
2-O
[8]  
CLARK GM, 1991, CANCER RES, V51, P944
[9]  
EBCTC Group, 1992, LANCET, V339, P1
[10]   THE NOTTINGHAM PROGNOSTIC INDEX IN PRIMARY BREAST-CANCER [J].
GALEA, MH ;
BLAMEY, RW ;
ELSTON, CE ;
ELLIS, IO .
BREAST CANCER RESEARCH AND TREATMENT, 1992, 22 (03) :207-219